Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry

Annals of Nuclear Medicine

Volumn 20, Issue 2, 2006, Pages 131-138

  Ito, Hiroshi ^a,b   Inoue, Kentaro ^a   Goto, Ryoi ^a   Kinomura, Shigeo ^a   Taki, Yasuyuki ^a   Okada, Ken ^a   Sato, Kazunori ^a   Sato, Tachio ^a   Kanno, Iwao ^c   Fukuda, Hiroshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

CBF; I 123 IMP; SPECT; Tc 99m ECD; Tc 99m HMPAO

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123; OXYGEN 15; TRACER;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN REGION; BRAIN TISSUE; CEREBROSPINAL FLUID FLOW; CONTROLLED STUDY; FEMALE; FIELD FLOW FRACTIONATION; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MORPHOMETRICS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

BRAIN; CEREBROVASCULAR CIRCULATION; CYSTEINE; DATABASES, FACTUAL; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; IOFETAMINE; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33645070196     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985625     Document Type: Article

References (44)

1. Kanno I, Lassen NA. Two methods for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr 1979; 3: 71-76.
2. 15O. I. Theory and error analysis. J Nucl Med 1983; 24: 782-789.
3. 15O autoradiographic method and positron emission tomography. J Cereb Blood Flow Metab 1987; 7: 143-153.
4. Winchell HS, Baldwin RM, Lin TH. Development of I-123-labeled amines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain. J Nucl Med 1980; 21: 940-946.
5. 123I]p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med 1980; 21: 947-952.
6. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NT, Gvozdanovic D, et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986; 27: 171-177.
7. Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, et al. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987; 28: 191-202.
8. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary DH, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, part 1: pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med 1989; 30: 1892-1901.
9. Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. J Nucl Med 1989; 30: 1902-1910.
10. Ballinger JR, Reid RH, Gulenchyn KY. Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione. J Nucl Med 1988; 29: 1998-2000.
11. Walovitch RC, Cheesman EH, Maheu LJ, Hall KM. Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD). J Cereb Blood Flow Metab 1994; 14 Suppl 1: S4-11.
12. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, et al. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 1997; 38: 587-592.
13. 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Eur J Nucl Med Mol Imaging 2003; 30: 1489-1497.
14. 133Xe dissolved in saline. Acta Neurol Scand Suppl 1965; 14: 65-68.
15. Ingvar DH, Cronqvist S, Ekberg R, Risberg J, Hoedt-Rasmussen K. Normal values of regional cerebral blood flow in man, including flow and weight estimates of gray and white matter. A preliminary summary. Acta Neurol Scand Suppl 1965; 14: 72-78.
16. Hoedt-Rasmussen K, Sveinsdottir E, Lassen NA. Regional cerebral blood flow in man determined by intra-arterial injection of radioactive inert gas. Circ Res 1966; 18: 237-247.
17. Iida H, Law I, Pakkenberg B, Krarup-Hansen A, Eberl S, Holm S, et al. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison. J Cereb Blood Flow Metab 2000; 20: 1237-1251.
18. Law I, Iida H, Holm S, Nour S, Rostrup E, Svarer C, et al. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: II. Normal values and gray matter blood flow response to visual activation. J Cereb Blood Flow Metab 2000; 20: 1252-1263.
19. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
20. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36.
21. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001; 14: 685-700.
22. Kimura K, Hashikawa K, Etani H, Uehara A, Kozuka T, Moriwaki H, et al. A new apparatus for brain imaging: four-head rotating gamma camera single-photon emission computed tomograph [see comments]. J Nucl Med 1990; 31: 603-609.
23. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638-643.
24. Chang LT. Attenuation correction and incomplete projection in single photon emission computed tomography. IEEE Trans Nucl Sci 1979; 26: 2780-2789.
25. Iida H, Miura S, Kanno I, Ogawa T, Uemura K. A new PET camera for noninvasive quantitation of physiological functional parametric images: Headtome-V-dual. In: Myers R, Cunningham V, Bailey D, Jones T, eds. Quantification of brain function using PET. San Diego; Academic Press, 1996: 57-61.
26. 15O autoradiography and positron emission tomography, with respect to the dispersion of the input function. J Cereb Blood Flow Metab 1986; 6: 536-545.
27. 15O]water and dynamic positron emission tomography. J Cereb Blood Flow Metab 1988; 8: 285-288.
28. 15O. II. Implementation and validation. J Nucl Med 1983; 24: 790-798.
29. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990; 10: 458-466.
30. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205-1210.
31. Crone C. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963; 58: 292-305.
32. 123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab 1996; 16: 781-793.
33. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001; 21: 1472-1479.
34. Ito H, Kanno I, Iida H, Hatazawa J, Shimosegawa E, Tamura H, et al. Arterial fraction of cerebral blood volume in humans measured by positron emission tomography. Ann Nucl Med 2001; 15: 111-116.
35. Iida H, Narita Y, Kado H, Kashikura A, Sugawara S, Shoji Y, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med 1998; 39: 181-189.
36. Ito H, Iida H, Kinoshita T, Hatazawa J, Okudera T, Uemura K. Effects of scatter correction on regional distribution of cerebral blood flow using I-123-IMP and SPECT. Ann Nucl Med 1999; 13: 331-336.
37. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 1155-1162.
38. Rodriguez G, Vitali P, Calvini P, Bordoni C, Girtler N, Taddei G, et al. Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Res 2000; 100: 65-74.
39. Callen DJ, Black SE, Caldwell CB. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET. Eur J Nucl Med Mol Imaging 2002; 29: 899-906.
40. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002; 73: 657-664.
41. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003; 18: 895-907.
42. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002; 13: 1939-1943.
43. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med 1998; 39: 293-298.
44. Kitayama N, Matsuda H, Ohnishi T, Kogure D, Asada T, Uno M, et al. Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun 2001; 22: 473-477.